https://www.diabetesmine.com/2013/04/the-worlds-funnest-clinical-trial-artificial-pancreas.html/comment-page-1?replytocom=610704

“If you’re always shooting for a perfect number, say 120, then the system has to constantly make adjustments and can never really catch up. But if you think about staying in a reasonable zone, or ‘zone control’ as we call it, you can achieve better results, and then you can make the zone tighter as treatment progresses,” he said.

He’s using this concept in other AP studies, including one that kicked off Feb. 12 using Afrezza inhalable insulin from MannKind. That study includes a total of 12 people (studied 2 at a time) hooked up to a similar AP tech system, who are given a small dose of the inhaled insulin at the start of each meal to mimic the cephalic, or first-phase insulin secretion. As we all know, speed of insulin action is a barrier to improved glucose control, and the Afrezza apparently kicks in very quickly.

Maybe she should post all her hedgefund husbands short positions?

http://www.raps.org/focus-online/news/news-article-view/article/3250/patients-first-fdas-new-website-aims-to-make-regulations-clear-to-everyone-invi.aspx

Hi guys

New member here. Been following this board for the last 6 months and really appreciate the real info provided without the bashing and pumping over at yahoo board. Im a long with both common and jan 15 leaps.

Love when the stock runs up like this but am awfully suspicious. Last time we ran up over 3 bucks we saw the biggest dilution follow the next week.

Hoping we dont see that again. Could there be info on partners coming out? I would think big pharma would want to see trial results and Al would wait to get a better deal with results in hand.

Has to be some news for stock to spike this early? I was expecting this but thought it would run in june or July prior to expected trial results in August. Any theories?